FDA Reports Low Contaminant Levels in Largest U.S. Infant Formula Study
The FDA’s comprehensive testing of over 300 infant formula samples found low contaminant levels, affirming the safety of the U.S. formula supply while promising…
Category
Health & Public Health
Health & Public Health covers major developments in healthcare, medicine, medical research, public health, food safety, health policy, insurance, drug safety, and safety issues affecting readers in the United States and around the world. This section focuses on clear, factual reporting from credible sources, including government health agencies, medical research institutions, public health organizations, and trusted news outlets. Coverage may include FDA updates, NIH research, disease prevention, healthcare costs, medication safety, public health alerts, hospital systems, and policy decisions that affect patients and communities.
FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List
The FDA proposes to exclude three diabetes-related drugs from the list of bulk substances allowed for compounding by outsourcing facilities due to lack of…
FDA Approves Auvelity for Agitation in Alzheimer’s Dementia
The FDA authorized Auvelity as the first non-antipsychotic treatment for agitation symptoms in adults with Alzheimer’s disease dementia
FDA Approves Expanded Access for Pancreatic Cancer Drug Daraxonrasib
The FDA has authorized expanded access use of the experimental drug daraxonrasib for patients with metastatic pancreatic cancer who have exhausted other treatments
NIH Awards $150,000 to Teams Innovating Nutrition Research in Autoimmune Disease
Fifteen scientific teams received $10,000 each from the NIH for innovative approaches linking diet and nutrition to autoimmune disease onset and management
Suspected Hantavirus Outbreak Kills Three on Cruise Ship Near Cape Verde
A hantavirus infection aboard the MV Hondius cruise ship has resulted in three deaths and multiple illnesses while authorities work to contain the outbreak
NIH Discovers Novel Opioid Providing Pain Relief With Lower Addiction Risk
NIH researchers identified a new opioid compound that offers strong pain relief without typical addictive or respiratory side effects, showing promise for safer pain…
NIH Trial Finds Team-Based Care Lowers Blood Pressure in Low-Income Patients
A scalable care model in federally qualified health centers significantly reduced systolic blood pressure among underserved Americans with hypertension
Dr. Jonathan M. Green Named CEO of NIH Clinical Center
Dr. Jonathan M. Green will lead the NIH Clinical Center, overseeing its operations and expansion starting May 2026
NIH Trial Finds No Outcome Difference Between IV Fluids in Pediatric Septic Shock
A major NIH-supported study compared balanced crystalloid fluid and 0.9% saline in children with septic shock and found no significant differences in death or…